Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Maschera
Cross-Resistance Analysis of Human Immunodeficiency Virus Type 1 Variants Individually Selected for Resistance to Five Different Protease Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Loss of Viral Fitness Associated With Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors in Vivo
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In vitroSequential Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants With Reduced Sensitivity to Hydroxyethylurea Protease Inhibitors
Antiviral Chemistry and Chemotherapy
Medicine
Virology
Drug Discovery
Pharmacology
Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance Within Unselected Virus Populations in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
